FindTrial
Sign In

The impact of low dose dexamethasone treatment upon clinical outcomes in patients undergoing surgically treated intracerebral hemorrhage intracerebral hemorrhage

The impact of low dose dexamethasone treatment upon clinical outcomes in patients undergoing surgically treated intracerebral hemorrhage intracerebral hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064624
Enrollment
Unknown
Registered
2022-10-13
Start date
2022-10-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage

Interventions

DEX group:Intravenous dexamethasone
NODEX group :No intravenous dexamethasone

Sponsors

Meizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. All 18 years and older individuals with the spontaneous intracerebral hemorrhage who underwent neurosurgery operation under general anesthesia were included.

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone multiple surgeries; 2. Patients without Glasgow score, preoperative computed tomography (CT) examination, laboratory results, bleeding volume, or surgical time.

Design outcomes

Primary

MeasureTime frame
30-day mortality;Length of hospital stay;Blood glucose;Gastrointestinal bleeding;—

Secondary

MeasureTime frame
Hospital-acquired pneumonia;—

Countries

China

Contacts

Public ContactYuanjun Zhou

Meizhou People's Hospital

dr_chou@163.com+86 18825481529

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026